Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors

Journal of Clinical Investigation

Volumn 121, Issue 7, 2011, Pages 2614-2624

  Kardava, Lela ^a   Moir, Susan ^a   Wang, Wei ^a   Ho, Jason ^a   Buckner, Clarisa M ^a   Posada, Jacqueline G ^a   O'Shea, Marie A ^a,c   Roby, Gregg ^a   Chen, Jenny ^a,b,d   Sohn, Hae Won ^a   Chun, Tae Wook ^a   Pierce, Susan K ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; FC RECEPTOR; FC RECEPTOR LIKE 4; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY CELL; PRIORITY JOURNAL;

ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; HIV; HIV INFECTIONS; HUMANS; RECEPTORS, ANTIGEN, B-CELL; RNA, SMALL INTERFERING;

EID: 79960011154     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45685     Document Type: Article

References (40)

1. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235-245.
2. Moir S, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797-1805.
3. Day CL, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350-354. (Pubitemid 44435155)
4. Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670-684. (Pubitemid 47615511)
5. Kaufmann DE, et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol. 2007;8(11):1246-1254. (Pubitemid 350011764)
6. Blackburn SD, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10(1):29-37.
7. Thomas ML. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. J Exp Med. 1995;181(6):1953-1956.
8. Nitschke L. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr Opin Immunol. 2005;17(3):290-297. (Pubitemid 40692664)
9. Veillette A, Latour S, Davidson D. Negative regulation of immunoreceptor signaling. Annu Rev Immunol. 2002;20:669-707. (Pubitemid 34293437)
10. Pritchard NR, Smith KG. B cell inhibitory receptors and autoimmunity. Immunology. 2003;108(3):263-273. (Pubitemid 36332384)
11. Ehrhardt GR, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202(6):783-791. (Pubitemid 41345967)
12. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A. 2003;100(23):13489-13494. (Pubitemid 37444769)
13. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010;10(1):11-23.
14. Hannon GJ. RNA interference. Nature. 2002;418(6894):244-251. (Pubitemid 34773784)
15. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007;6(6):443-453. (Pubitemid 47064567)
16. Seiffert M, Stilgenbauer S, Dohner H, Lichter P. Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia. 2007;21(9):1977-1983. (Pubitemid 47299973)
17. Lonza. Amaxa Human B Cell Nucleofector Kit. 2009. http://www.lonzabio. com/resources/product-instructions/protocols/. Published 2009. Accessed May 9, 2011.
18. Lonza. Amaxa Human T Cell Nucleofector Kit. http://www.lonzabio.com/ resources/product-instructions/protocols/. Published 2009. Accessed May 9, 2011.
19. Daeron M, et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity. 1995;3(5):635-646.
20. Velu V, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2009;458(7235):206-210.
21. Isnardi I, et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026-5036.
22. Segundo C, Medina F, Rodriguez C, Martinez-Palencia R, Leyva-Cobian F, Brieva JA. Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis. Blood. 1999;94(3):1012-1020. (Pubitemid 29361833)
23. Hawkins ED, Hommel M, Turner ML, Battye FL, Markham JF, Hodgkin PD. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat Protoc. 2007;2(9):2057-2067. (Pubitemid 351565843)
24. Capolunghi F, et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol. 2008;180(2):800-808.
25. Malaspina A, et al. CpG oligonucleotides enhance proliferative and effector responses of B cells in HIV-infected individuals. J Immunol. 2008;181(2):1199-1206.
26. Huggins J, et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood. 2007;109(4):1611-1619. (Pubitemid 46239595)
27. Malaspina A, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A. 2006;103(7):2262-2267. (Pubitemid 43271658)
28. Avery DT, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155-171.
29. Cao Y, et al. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body. J Immunol Methods. 2010;358(1-2):56-65.
30. Liu W, Meckel T, Tolar P, Sohn HW, Pierce SK. Intrinsic properties of immunoglobulin IgG1 isotypeswitched B cell receptors promote microclustering and the initiation of signaling. Immunity. 2010;32(6):778-789.
31. Horikawa K, et al. Enhancement and suppression of signaling by the conserved tail of IgG memorytype B cell antigen receptors. J Exp Med. 2007;204(4):759-769. (Pubitemid 46631606)
32. Waisman A, et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med. 2007;204(4):747-758. (Pubitemid 46631605)
33. Gauld SB, Dal Porto JM, Cambier JC. B cell antigen receptor signaling: roles in cell development and disease. Science. 2002;296(5573):1641-1642. (Pubitemid 34579149)
34. Monroe JG. Ligand-independent tonic signaling in B-cell receptor function. Curr Opin Immunol. 2004;16(3):288-295. (Pubitemid 38595367)
35. Srinivasan L, et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell. 2009;139(3):573-586.
36. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev. 2009;229(1):152-172.
37. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity. 2000;13(2):277-285.
38. Cady CT, Rice JS, Ott VL, Cambier JC. Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors. Immunol Rev. 2008;224:44-57.
39. Titanji K, et al. Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques. J Clin Invest. 2010;120(11):3878-3890.
40. Moir S, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A. 2001;98(18):10362-10367. (Pubitemid 32803025)